about
Combined modality therapy for thoracic and head and neck cancers: a review of updated literature based on a consensus meeting.Marrow damage and hematopoietic recovery following allogeneic bone marrow transplantation for acute leukemias: Effect of radiation dose and conditioning regimen.A biologically competitive 21 days hypofractionation scheme with weekly concomitant boost in breast cancer radiotherapy feasibility acute sub-acute and short term late effectsMulti-institutional feasibility study of a fast patient localization method in total marrow irradiation with helical tomotherapy: a global health initiative by the international consortium of total marrow irradiationIntensified intensity-modulated radiotherapy in anal cancer with prevalent HPV p16 positivityImage guided hypofractionated radiotherapy by helical tomotherapy for prostate carcinoma: toxicity and impact on Nadir PSA.Predictability, efficacy and safety of radiosensitization of glioblastoma-initiating cells by the ATM inhibitor KU-60019.Pharmacokinetics, pharmacodynamics and efficacy on pediatric tumors of the glioma radiosensitizer KU60019.Helical tomotherapy targeting total bone marrow after total body irradiation for patients with relapsed acute leukemia undergoing an allogeneic stem cell transplant.Accelerated partial breast irradiation via the mammosite catheter: preliminary reports of a single-institution experience.Radiosurgery with Helical Tomotherapy: Outcomes for Patients with One or Multifocal Brain Metastasis.Faithful animal modelling of human glioma by using primary initiating cells and its implications for radiosensitization therapy [ARRIVE 1]Author Correction: Faithful animal modelling of human glioma by using primary initiating cells and its implications for radiosensitization therapyAdvances in the implementation of helical tomotherapy-based total marrow irradiation with a novel field junction techniqueMulti-institutional evaluation of MVCT guided patient registration and dosimetric precision in total marrow irradiation: A global health initiative by the international consortium of total marrow irradiationExtra-pleural pneumonectomy in the era of image-guided intensity-modulated radiotherapyCall for ensuring cancer care continuity during COVID-19 pandemic
P50
Q30248531-C299ED4B-B297-42AB-9D23-433465299CD7Q33428284-EC64A9A4-81A2-4808-A7EB-02A9C00FF33FQ34408374-55E325AB-1132-49F3-BC19-F8BE3AC037A5Q35268812-73C40B14-3997-464F-8DDA-7D682BD00F77Q36105656-91A5548C-E28C-45B3-9C55-1C08BE0C2713Q37686861-601384E1-1B71-466C-82BB-9C2396DC4DDFQ39032882-44084A6E-AC70-4208-8552-BE9E5BC961C1Q48621553-448386F0-0B86-4974-846C-50BD7A3B3C96Q53243120-052113AC-6F9E-430B-ACB5-0AD79CE6D107Q53320097-4F385335-20B0-4237-90E8-984B2F5EC0A9Q54418104-71B3EDF3-58A9-46B5-8C6B-D4B422032F27Q58705906-AD5E633A-A29C-46A3-A4B4-69CAA9A2CA9DQ64093065-2660E9FA-8DE7-4FA9-8D26-8F6D8857A6C8Q83426764-E18DDCC9-27CD-4D4F-B905-DE93283BAF89Q92675580-B1172CB4-0DBA-4C7D-BBFE-D71B3A481F40Q92959923-AB6A9D0A-37A7-44AD-9174-3096072B736DQ94547845-5892FAB1-B70D-47E5-8BE0-A10DB466581D
P50
description
researcher ORCID ID = 0000-0002-8212-7069
@en
wetenschapper
@nl
name
Stefano Vagge
@ast
Stefano Vagge
@en
Stefano Vagge
@es
Stefano Vagge
@nl
type
label
Stefano Vagge
@ast
Stefano Vagge
@en
Stefano Vagge
@es
Stefano Vagge
@nl
prefLabel
Stefano Vagge
@ast
Stefano Vagge
@en
Stefano Vagge
@es
Stefano Vagge
@nl
P106
P1153
35742063000
P21
P31
P496
0000-0002-8212-7069